Original Article
Low expression of KLRB1 predicts poor survival outcomes and is associated with immune infiltration in breast cancer
Translational Cancer Research
2024;
13
(3)
:1225-1240
.
(31 March 2024)
CCND2 is a prognostic biomarker and correlates with immune infiltration in lung adenocarcinoma
Translational Cancer Research
2024;
13
(3)
:1241-1251
.
(31 March 2024)
A novel immune-related long noncoding RNA (lncRNA) pair model to predict the prognosis of triple-negative breast cancer
Translational Cancer Research
2024;
13
(3)
:1252-1267
.
(31 March 2024)
Cuproptosis-related molecular classification and gene signature of hepatocellular carcinoma and experimental verification
Translational Cancer Research
2024;
13
(3)
:1268-1289
.
(31 March 2024)
Identification and validation of the clinical prediction model and biomarkers based on chromatin regulators in colon cancer by integrated analysis of bulk- and single-cell RNA sequencing data
Translational Cancer Research
2024;
13
(3)
:1290-1313
.
(31 March 2024)
Predictors of mortality in hospitalized African American COVID-19 patients with cancer
Translational Cancer Research
2024;
13
(3)
:1314-1322
.
(31 March 2024)
Nomograms for predicting prognostic value of combined neutrophil-to-lymphocyte ratio and SCC-Ag in locally advanced cervical cancer
Translational Cancer Research
2024;
13
(3)
:1323-1335
.
(31 March 2024)
Comprehensive analysis of disulfidptosis-related lncRNAs for predicting prognosis and response of immunotherapy in pancreatic adenocarcinoma
Translational Cancer Research
2024;
13
(3)
:1336-1350
.
(31 March 2024)
Construction and validation of a prognostic model for stemness-related genes in lung adenocarcinoma
Translational Cancer Research
2024;
13
(3)
:1351-1366
.
(31 March 2024)
Identification of an immune-related signature as a prognostic classifier for patients with early-stage head and neck squamous cell carcinoma
Translational Cancer Research
2024;
13
(3)
:1367-1381
.
(31 March 2024)
A four-gene signature predicts overall survival of patients with esophageal adenocarcinoma
Translational Cancer Research
2024;
13
(3)
:1382-1393
.
(31 March 2024)
Comprehensive analysis of exosome gene LYPD3 and prognosis/immune cell infiltration in lung cancer
Translational Cancer Research
2024;
13
(3)
:1394-1405
.
(31 March 2024)
A pyroptosis-related lncRNA-based prognostic index for hepatocellular carcinoma by relative expression orderings
Translational Cancer Research
2024;
13
(3)
:1406-1424
.
(31 March 2024)
Modeling of new markers for the diagnosis and prognosis of pancreatic cancer based on the transition from inflammation to cancer
Translational Cancer Research
2024;
13
(3)
:1425-1442
.
(31 March 2024)
CLCN3 in mediating the proliferation of human ovarian cancer cells
Translational Cancer Research
2024;
13
(3)
:1443-1457
.
(31 March 2024)
The prognostic biomarker TPGS2 is correlated with immune infiltrates in pan-cancer: a bioinformatics analysis
Translational Cancer Research
2024;
13
(3)
:1458-1478
.
(31 March 2024)
Gastric cancer prognosis: unveiling autophagy-related signatures and immune infiltrates
Translational Cancer Research
2024;
13
(3)
:1479-1492
.
(31 March 2024)
The activation of HAMP promotes colorectal cancer cell proliferation through zinc-mediated upregulation of SMAD4 expression
Translational Cancer Research
2024;
13
(3)
:1493-1507
.
(31 March 2024)
Liver-directed moderately hypo-fractionated radiotherapy combined with pembrolizumab and bevacizumab for advanced hepatocellular carcinoma: a retrospective observational study of 23 cases
Translational Cancer Research
2024;
13
(3)
:1508-1518
.
(31 March 2024)
Machine learning methods predict recurrence of pN3b gastric cancer after radical resection
Translational Cancer Research
2024;
13
(3)
:1519-1532
.
(31 March 2024)
RAC1 as a potential pan-cancer diagnostic, prognostic, and immunological biomarker
Translational Cancer Research
2024;
13
(3)
:1533-1553
.
(31 March 2024)
A novel PD-1/PD-L1 pathway-related seven-gene signature for the development and validation of the prognosis prediction model for breast cancer
Translational Cancer Research
2024;
13
(3)
:1554-1566
.
(31 March 2024)
Segmentation method of magnetic resonance imaging brain tumor images based on improved UNet network
Translational Cancer Research
2024;
13
(3)
:1567-1583
.
(31 March 2024)
Review Article
Application and progress of CRISPR/Cas9 gene editing in B-cell lymphoma: a narrative review
Translational Cancer Research
2024;
13
(3)
:1584-1595
.
(31 March 2024)
